Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 23;9(1):37.
doi: 10.3390/jcm9010037.

Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology

Iacopo Fabiani  1 , Alessandro Colombo  1   2 , Giulia Bacchiani  1   2 , Carlo Maria Cipolla  2 , Daniela Maria Cardinale  1
Affiliations
Review

Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology

Iacopo Fabiani et al. J Clin Med. .

Abstract

Atrial fibrillation (AF) is a common supraventricular arrhythmia, a recognized risk factor for ischemic stroke, as a potential driver for heart failure (HF). Cancer patients have an increased risk for AF, even not including any cancer-specific treatment, as surgery or chemotherapy. The mechanism is multifactorial, with inflammation and changes in autonomic tone as critical actors. Commonly, AF is a recurrent complication of the post-operative period in cancer surgery (especially thoracic). Recent papers confirmed a significant incidence of post-operative (non-cardiac surgery) AF (PAF), partially mitigated by the use of prophylactic (rate o rhythm control) treatments. A relevant difference, in terms of mean hospitalization time, emerges between patients developing PAF and those who do not, while long term impact remains a matter of debate, due to several potential confounding factors. Besides clinical predictors, structural (i.e., echocardiographic) and bio-humoral findings may help in risk prediction tasks. In this respect, pre-operative natriuretic peptides (NPs) concentrations are nowadays recognized as significant independent predictors of perioperative cardiovascular complications (including PAF), while elevated post-operative levels may further enhance risk stratification. The aim of the present paper is to trace the state of the art in terms of incidence, management, prevention, and outcome of PAF in the field of thoracic surgical oncology.

Keywords: N-terminal-pro-natriuretic peptide; atrial fibrillation; brain natriuretic peptide; cancer; cardiotoxicity; thoracic surgery; thrombosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Daily distribution of post-operative atrial fibrillation—Pooled data with permission from [22,30,31], showing cumulative incidence of post-operative atrial fibrillation episodes, according to days after operation.
Figure 2
Figure 2
Graphical depiction of post-operative atrial fibrillation «milieu»—Independent predictors derived from principal studies from literature are in boxes, according to their type. Contributing mechanisms, including electro-physiological ones, are in blue.
See this image and copyright information in PMC

References

    1. Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castella M., Diener H.C., Heidbuchel H., Hendriks J., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016;37:2893–2962. doi: 10.1093/eurheartj/ehw210. - DOI - PubMed
    1. Ferreira C., Providência R., Ferreira M.J., Gonçalves L.M. Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review. Arq. Bras. Cardiol. 2015;105:519–526. doi: 10.5935/abc.20150142. - DOI - PMC - PubMed
    1. Conen D., Wong J.A., Sandhu R.K., Cook N.R., Lee I.M., Buring J.E., Albert C.M. Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation. JAMA Cardiol. 2016;1:389–396. doi: 10.1001/jamacardio.2016.0280. - DOI - PMC - PubMed
    1. Guzzetti S., Costantino G., Sada S., Fundarò C. Colorectal cancer and atrial fibrillation: A case-control study. Am. J. Med. 2002;112:587–588. doi: 10.1016/S0002-9343(02)01029-X. - DOI - PubMed
    1. Erichsen R., Christiansen C.F., Mehnert F., Weiss N.S., Baron J.A., Sørensen H.T. Colorectal cancer and risk of atrial fibrillation and flutter: A population-based case-control study. Intern. Emerg. Med. 2012;7:431–438. doi: 10.1007/s11739-011-0701-9. - DOI - PubMed